Last Updated: July 2026
Caffeine and EGCG are chemically distinct — caffeine is a moderately polar alkaloid, while EGCG is a larger, more polar polyphenol. Any decaffeination process that fails to account for this difference in polarity risks stripping out valuable catechins along with the targeted caffeine, directly reducing the finished extract's EGCG specification.
Supercritical carbon dioxide behaves as a non-polar to low-polarity solvent under controlled temperature and pressure conditions. Because caffeine has significantly higher solubility in CO2 than the more polar catechin compounds, this method allows selective caffeine removal with comparatively limited co-extraction of EGCG and other polyphenols. CO2 also leaves no residual solvent in the final product, since it reverts to gas form upon depressurization.
Ethyl acetate processing — sometimes marketed as a "natural process" in the coffee industry because the solvent can be derived from natural fermentation esters — sits between CO2 and water in polarity. This intermediate polarity means ethyl acetate can co-extract a higher proportion of polyphenols than CO2 processing, and finished extracts require thorough solvent residue testing to confirm compliance with food-grade solvent limits.
Because both caffeine and EGCG are water-soluble, a simple water extraction removes both compounds simultaneously. To achieve decaffeination without proportionally destroying EGCG content, water-based processes typically require a secondary selective adsorption step — such as activated carbon or resin filtration tuned for caffeine affinity — followed by reintroduction of the retained polyphenol-rich solution back into the process stream. This approach is conceptually similar to the "Swiss Water Process" used in decaffeinated coffee production.
| Method | Selectivity for Caffeine over EGCG | Solvent Residue Consideration |
|---|---|---|
| Supercritical CO2 | High — low polarity favors caffeine extraction | None; CO2 reverts to gas, no residue |
| Ethyl Acetate | Moderate — intermediate polarity co-extracts more polyphenols | Requires residual solvent testing (GC method) |
| Water-Only (with selective adsorption) | Depends entirely on adsorbent selectivity, not water itself | No organic solvent residue; adsorbent material must be food-grade certified |
For products carrying USDA Organic certification, the processing aids and solvents used in decaffeination must comply with the National Organic Program's permitted substances framework. Synthetic solvents are generally restricted under this framework, which is a key reason CO2 and water-based processing are more commonly compatible with organic-certified supply chains than solvent-based alternatives.
Regarding "natural" labeling specifically, it is important to note that the U.S. FDA has never issued a formal legal definition of the term "natural" for food labeling purposes. The agency has historically maintained only an informal policy position — that it does not object to the term's use when a product contains no added color, artificial flavors, or synthetic substances — rather than a codified regulatory standard. See the FDA's current guidance on natural labeling for the agency's official position.
| # | Audit Item |
|---|---|
| 1 | Confirm which decaffeination method was used and request process documentation |
| 2 | Compare EGCG/total polyphenol content before and after decaffeination on the COA |
| 3 | If ethyl acetate is used, request residual solvent test results (GC method) |
| 4 | If organic certification is required, verify the decaffeination processing aid complies with 7 CFR 205.605 |
Q: Is CO2-decaffeinated green tea extract automatically organic-certified?
A: No, CO2 processing is generally more compatible with organic certification requirements than synthetic solvent methods, but organic certification itself requires a separate, complete supply chain audit beyond just the decaffeination step.
Q: Can I legally label ethyl acetate-decaffeinated extract as "natural"?
A: The FDA has no formal legal definition of "natural," only an informal policy position on the term; labeling decisions should be reviewed against current FDA guidance and any applicable state-level requirements before finalizing claims.